IDENTIFIKASI INTERAKSI OBAT-OBAT POTENSIAL PADA PASIEN GAGAL GINJAL KRONIK RSPAD GATOT SOEBROTO
Abstract
Drug interactions are directly related to factors such as polypharmacy, aging, hepatic metabolism and decreased renal function. Polypharmacy is common in drug prescriptions of chronic kidney disease patients. A study of the prescription patterns of drugs with potential interactions would be of interest to prevent drug related adverse events. The aim of this study was to identify potential drug-drug interactions among chronic kidney disease among hospitalized patients in Gatot Soebroto Army Hospital, Jakarta period October to December 2015 This study was an observational research with descriptive approach. Data were obtained retrospectively. Data was collected from patient's medical record. The sampels were hospitalized patients with chronic kidney disease in Gatot Soebroto Army Hospital, Jakarta period October to December 2015 that received at least two drugs in one prescribing pattern. The samples which fulfilled the inclusion criteria were 63 patients and found as many as 443 potential drug interactions. Drug interactions with pharmacodynamic mechanism were 235 cases (53.04%) and pharmacokinetics as much as 208 cases (46.96%). A total of 334 cases (75.39%) were drug interactions with moderate severity. drug interactions are commonly seen in the prescriptions of chronic kidney disease patients which can lead to serious adverse events if not detected early.
Full text article
References
Grossman S. 2009. Acute Renal Injury and Chronic Kidney Disease. Dalam: Porth Parthophysiology Concepts of Altered Health States. Philadelphi. Hlm 998, 1122
Glintborg B, Andersen SE & Dalhoff K. (2005). Drug-drug interactions among recently hospitalised patients-frequent but mostly clinically insignificant. European Journal of Clinical Pharmacolology. Vol 61, Hal 675–681.
Hansten PD. 2003. Drug interaction management. Pharmacy World & Science Journals. 25 : 94–7
Kementerian Kesehatan RI. 2013. Riset Kesehatan Dasar (RISKESDAS) 2013. Jakarta
Mahmood M, Malone DC, Skrepnek GH, Abarka J, Armstrong EP, Murphy JE, et al. 2007. Potential drug-drug interactions within veterans affairs medical centers. American Journal of Health-System Pharmacy. 64:1500–5.
Marquito AB, Fernandes NMDS, Colugnati FAB, Paula RBD. 2014. Identifying potential drug interaction drug interaction in chronic kidney disease patient. Hlm 6.
Nagi CH. 2015. Studi Literatur Interaksi Obat Pada Peresepan Pasien Gagal Ginjal Kronik di Instalansi Rawat Jalan RSUD Panembahan Senopati Bantul Yogyakarta Periode Desember 2015. Yogyakarta : Skripsi. Jurusan Farmasi Universitas Sanata Dharma. Hlm. 21
Pranandari R, Supadmi W. 2015. Faktor Risiko Gagal Ginjal Kronik di Unit Hemodialisa RSUD Wates Kulon Progo. Fakultas Farmasi Universitas Ahmad Dahlan Yogyakarta. Majalah Farmasi Indonesia. Hlm 2
Rama, M., Viswanathan, G., Acharya,D., Attur, PR., Reddy, N P., Raghavan,VS. 2012. Assessment of Drug-Drug Interaction among Renal Failure Patients of Nephrology Ward in a South Indian Tertiary Care Hospital. Indian journal of pharmaceutical Sciences. 74(1): 63–68
Sibuea WH, Panggabean MM, Gultom SP. 2005. Ilmu Penyakit Dalam. Rineka Cipta. Jakarta. Hlm. 266 – 269
Stockley, I.H. 2010. Drug Interactions 9th Edition. The Pharmaceutical Press, London UK. Hal 42, 49
Sundborn LT. 2012. Women and men report deferent behaviours in and reason for medication nonadherence: a nationwide Swedish survey. Journal of Pharmacy Practice, 10(4): 207-221.
Tatro DS. 2014. Drug Interaction Fact. Wolters Kluwer Health. United States Of America.
Wilson LM. 2005. Gagal Ginjal Kronik. Dalam : Price SA, Wilson LM. Patofisiologi Konsep Klinis Proses – Proses Penyakit. Terjemahan : Pendit BU, Hartanto H, Wulansari P, Mahanani DA. EGC. Jakarta. Hlm 912 – 919, 933, 968, 970